Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
Lenzen MJ, Boersma E, Reimer WJ, Balk AH, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JG. Lenzen MJ, et al. Eur Heart J. 2005 Dec;26(24):2706-13. doi: 10.1093/eurheartj/ehi499. Epub 2005 Sep 23. Eur Heart J. 2005. PMID: 16183692
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.
Hordijk-Trion M, Lenzen M, Wijns W, de Jaegere P, Simoons ML, Scholte op Reimer WJ, Bertrand ME, Mercado N, Boersma E; EHS-CR Investigators. Hordijk-Trion M, et al. Among authors: lenzen m. Eur Heart J. 2006 Mar;27(6):671-8. doi: 10.1093/eurheartj/ehi731. Epub 2006 Jan 19. Eur Heart J. 2006. PMID: 16423872
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Lenzen M, Ryden L, Ohrvik J, Bartnik M, Malmberg K, Scholte Op Reimer W, Simoons ML; Euro Heart Survey Investigators. Lenzen M, et al. Eur Heart J. 2006 Dec;27(24):2969-74. doi: 10.1093/eurheartj/ehl363. Epub 2006 Nov 7. Eur Heart J. 2006. PMID: 17090612
New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey.
Rivero-Ayerza M, Scholte Op Reimer W, Lenzen M, Theuns DA, Jordaens L, Komajda M, Follath F, Swedberg K, Cleland JG. Rivero-Ayerza M, et al. Among authors: lenzen m. Eur Heart J. 2008 Jul;29(13):1618-24. doi: 10.1093/eurheartj/ehn217. Epub 2008 May 31. Eur Heart J. 2008. PMID: 18515809 Free article.
The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
Simsek C, Garcia-Garcia HM, van Geuns RJ, Magro M, Girasis C, van Mieghem N, Lenzen M, de Boer S, Regar E, van der Giessen W, Raichlen J, Duckers HJ, Zijlstra F, van der Steen T, Boersma E, Serruys PW; Integrated Biomarker and Imaging Study-3 investigators. Simsek C, et al. Among authors: lenzen m. EuroIntervention. 2012 Jun 20;8(2):235-41. doi: 10.4244/EIJV8I2A37. EuroIntervention. 2012. PMID: 22717926 Free article.
Life-years gained by smoking cessation after percutaneous coronary intervention.
de Boer SP, Serruys PW, Valstar G, Lenzen MJ, de Jaegere PJ, Zijlstra F, Boersma E, van Domburg RT; interventional cardiologists of the Thoraxcentre 1980 to 1985. de Boer SP, et al. Among authors: lenzen mj. Am J Cardiol. 2013 Nov 1;112(9):1311-4. doi: 10.1016/j.amjcard.2013.05.075. Epub 2013 Jul 25. Am J Cardiol. 2013. PMID: 23891246
Determinants of high cardiovascular risk in relation to plaque-composition of a non-culprit coronary segment visualized by near-infrared spectroscopy in patients undergoing percutaneous coronary intervention.
de Boer SP, Brugaletta S, Garcia-Garcia HM, Simsek C, Heo JH, Lenzen MJ, Schultz C, Regar E, Zijlstra F, Boersma E, Serruys PW. de Boer SP, et al. Among authors: lenzen mj. Eur Heart J. 2014 Feb;35(5):282-9. doi: 10.1093/eurheartj/eht378. Epub 2013 Sep 12. Eur Heart J. 2014. PMID: 24037276
Primary PCI during off-hours is not related to increased mortality.
de Boer SP, Oemrawsingh RM, Lenzen MJ, van Mieghem NM, Schultz C, Akkerhuis KM, van Leeuwen MA, Zijlstra F, van Domburg RT, Serruys PW, Boersma E. de Boer SP, et al. Among authors: lenzen mj. Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):33-9. doi: 10.1177/2048872612441581. Eur Heart J Acute Cardiovasc Care. 2012. PMID: 24062885 Free PMC article.
Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.
Diletti R, Karanasos A, Muramatsu T, Nakatani S, Van Mieghem NM, Onuma Y, Nauta ST, Ishibashi Y, Lenzen MJ, Ligthart J, Schultz C, Regar E, de Jaegere PP, Serruys PW, Zijlstra F, van Geuns RJ. Diletti R, et al. Among authors: lenzen mj. Eur Heart J. 2014 Mar;35(12):777-86. doi: 10.1093/eurheartj/eht546. Epub 2014 Jan 6. Eur Heart J. 2014. PMID: 24394380 Free article.
193 results